Skip to content

MEDIMEX

Active Risk: not assessed
Private limited companyfounded 200125 yrs activeRoute de la Navinne(ML) 136, 5020 Namur, BelgiumKBO/BCE: BE 0475.039.880
Summary

MEDIMEX is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.80M and a net result of €522k. Equity is growing by ~12.5% per year across the filed fiscal years. Its solvency ranks better than 90% of 33 sector peers (fiscal year 2025). The company has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Outside the general model
Model not applicable to financial institutions
The health score weighs liquidity, leverage and margins against norms for trading and manufacturing companies. A bank, insurer or financial holding has a fundamentally different balance-sheet structure, so those ratios, and hence the score, carry no meaning here. That is why we show no financial axes either.
Credit check for your own amount and term

Signals

1 signal. The signal on the left, the evidence on the right.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-05-2026, 63 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
63 d early
2024
8 d early
2023
27 d late
2022
8 d late
2021
82 d late
2020
88 d late
2019
90 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Equity
€1.80M▼ 23.8%
2024 · €2.36M
2018: €1.61M 2019: €1.15M 2020: €1.29M 2021: €1.48M 2022: €1.66M 2023: €1.97M 2024: €2.36M
2018 → 2025
Net result
€522k▲ 37.1%
2024 · €381k
2018: €146k 2019: €127k 2020: €143k 2021: €187k 2022: €186k 2023: €312k 2024: €381k
2018 → 2025
Total assets
€2.10M▼ 17.4%
2024 · €2.54M
2018: €1.62M 2019: €1.16M 2020: €1.31M 2021: €1.51M 2022: €1.75M 2023: €2.11M 2024: €2.54M
2018 → 2025
Solvency
85.5%▼ 7.1pp
2024 · 92.6%
2018: 99.2% 2019: 99.2% 2020: 98.8% 2021: 97.7% 2022: 95.1% 2023: 93.5% 2024: 92.6%
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€1.48M-€1.66M▲ 12.6%€1.97M▲ 18.7%€2.36M▲ 19.3%€1.80M▼ 23.8%
Operating result€278k-€275k▼ 1.1%€418k▲ 52.0%€514k▲ 23.0%€581k▲ 13.1%
Net result€187k-€186k▼ 0.6%€312k▲ 68.0%€381k▲ 22.2%€522k▲ 37.1%
Result per fiscal year
Operating resultNet result
€0€200k€400k€600kOperating result 2021: €278k€278kNet result 2021: €187k€187kOperating result 2022: €275k€275kNet result 2022: €186k€186kOperating result 2023: €418k€418kNet result 2023: €312k€312kOperating result 2024: €514k€514kNet result 2024: €381k€381kOperating result 2025: €581k€581kNet result 2025: €522k€522k20212022202320242025€0€200k€400k€600kOperating result 2023: €418k€418kNet result 2023: €312k€312kOperating result 2024: €514k€514kNet result 2024: €381k€381kOperating result 2025: €581k€581kNet result 2025: €522k€522k202320242025
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 13% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.10M
Fixed assets €40k ▼ 65.0%
Current assets €2.06M ▼ 15.2%
Equity and liabilities €2.10M
Equity €1.80M ▼ 23.8%
Debt €304k ▲ 61.8%
Debt's share of the balance-sheet total rises from 7.4% to 14.5%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
ROE
29.1%
2024 · 16.2%
ROA
24.9%
2024 · 15.0%
Debt ≤ 1 year
€304k
2024 · €188k
Income taxes
€237k
2024 · €172k
Staff costs
€46k
2024 · €42k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 53 lines
Balance sheet Code20242025
Assets
Total assets20/58€2.54M€2.10M
Fixed assets21/28€113k€40k
Tangible fixed assets22/27€113k€40k
Plant, machinery and equipment23€2k€1k
Furniture and vehicles24€111k€37k
Other tangible fixed assets26€543€834
Financial fixed assets28€50€50=
Current assets29/58€2.43M€2.06M
Amounts receivable within one year40/41€45k€68k
Trade receivables40€45k€68k
Other amounts receivable41€3-
Current investments50/53€2.15M€1.79M
Cash at bank and in hand54/58€229k€194k
Deferred charges and accrued income490/1€11k€13k
Equity and liabilities
Total equity and liabilities10/49€2.54M€2.10M
Equity10/15€2.36M€1.80M
Contributions10/11€13k€13k=
Reserves13€2.26M€1.78M
Tax-exempt reserves132€6k€6k=
Distributable reserves133€2.25M€1.78M
Profit (loss) carried forward14€82k-
Amounts payable17/49€188k€304k
Amounts payable within one year42/48€188k€304k
Trade debts44€26k€2k
Suppliers440/4€26k€2k
Taxes, remuneration and social security45€135k€140k
Taxes450/3€130k€135k
Remuneration and social security454/9€5k€5k
Other amounts payable47/48€27k€162k
Income statement Code20242025
Non-recurring operating income76A-€1k
Remuneration, social security and pensions62€42k€46k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€34k€15k
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4-€10k
Other operating charges640/8€1k€1k
Non-recurring operating charges66A-€16k
Gross operating margin9900€591k€670k
Operating profit (loss)9901€514k€581k
Financial income75/76B€44k€188k
Recurring financial income75€44k€188k
Financial charges65/66B€5k€11k
Recurring financial charges65€5k€11k
Profit (loss) for the period before taxes9903€553k€759k
Income taxes67/77€172k€237k
Profit (loss) for the period9904€381k€522k
Profit (loss) for the period to be appropriated9905€381k€522k
Appropriation of the result
Profit (loss) to be appropriated9906€463k€604k
Profit (loss) brought forward from the previous period14P€82k€82k=
Transfer from equity791/2-€1.08M
Transfer to equity691/2€381k€604k
To other reserves6921€381k€604k
Profit to be distributed694/7-€1.08M
Return on contributions (dividend)694-€1.08M
Social balance
Average headcount (FTE)9087-0.9

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
29-05
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial Highest result since 2018net €522k ▲37.1%
Operating result €581k, net result €522k, both a record.
23-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Equity above €2MEq €2.36M ▲19.3%
7 profitable years in a row build equity to €2.36M.
27-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 27 days late
2023
08-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 8 days late
2022
21-10
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 82 days late
2021
27-10
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 88 days late
2020
29-10
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 90 days late
2019
31-12
Financial Weakest financial yearnet €127k ▼13%
Net result drops to €127k, the lowest in the series; recovery starts the following year.
31-10
NBB filing Annual accounts filed
fiscal year 2018 · full schema · 92 days late
2018
23-11
NBB filing Annual accounts filed
fiscal year 2017 · full schema · 115 days late
2017
06-11
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 98 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Namur · 1 establishment unit since 2001
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Route de la Navinne(ML) 1365020 Namur
Ground area
1,468 m²
Building footprint
184 m²
Volume, LiDAR
1,839 m³
2 parcels, Wallonia · tallest building 15.7 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Rue Henri Lemaître 99, 5000 Namur
NACE 85120
since 20012.228.346.158
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
92082B0179/00D002 Wallonia 1,101 m² 1 · 114 m² 9.6 m · 3 fl.
92302G0218/00H004 Wallonia 366 m² 1 · 70 m² 15.7 m · 5 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

967600UTTJG456G77240
live in the LEI register

Similar companies · same sector, comparable size

Of 118 companies in sector 65121 we hold annual accounts for 34. 17 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded19-06-2001
Fiscal year end31-12
Activities, NACEBEL 2025
65121Insurance, reinsurance and pension funding, except compulsory social security
86210General medical practice
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 25 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.